Elkfork Partners’s Integra LifeSciences IART Stock Holding History

Elkfork Partners’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$637K	Hold	10,604	–	–	0.02%	512
2019 Q2	$592K	Sell	10,604 -330	-3%	-$17K	0.01%	530
2019 Q1	$609K	Buy	10,934 +1,408	+15%	+$71.7K	0.02%	512
2018 Q4	$430K	Buy	9,526 +506	+6%	+$27.8K	0.01%	557
2018 Q3	$594K	Buy	9,020 +2,288	+34%	+$142K	0.01%	546
2018 Q2	$434K	Hold	6,732	–	–	0.01%	570
2018 Q1	$373K	Hold	6,732	–	–	0.01%	614
2017 Q4	$322K	Buy	6,732 +1,298	+24%	+$63.5K	0.01%	659
2017 Q3	$274K	Buy	5,434 +814	+18%	+$41.8K	0.01%	646
2017 Q2	$252K	Buy	4,620 +1,408	+44%	+$67.2K	0.01%	627
2017 Q1	$135K	Buy	3,212 +308	+11%	+$13.2K	﹤0.01%	673
2016 Q4	$125K	Buy	+2,904	New	+$118K	﹤0.01%	683

Other funds holding IART

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Elkfork Partners's IART Position: Q3 2019 in Review

Elkfork Partners held its Integra LifeSciences (IART) position steady in Q3 2019 at 10,604 shares worth $637K. The position accounts for 0.02% of the portfolio, ranked #512.

Elkfork Partners first reported a position in IART in Q4 2016 and has held it in 12 quarters since. 280 funds tracked by Wall St. Rank hold IART as of Q3 2019.

Elkfork Partners held 10,604 shares of Integra LifeSciences worth $637K as of Q3 2019.
Elkfork Partners left its Integra LifeSciences share count unchanged in Q3 2019.
Integra LifeSciences made up 0.02% of Elkfork Partners's portfolio in Q3 2019, its #512 holding.
Elkfork Partners first reported a position in Integra LifeSciences in Q4 2016 and has held it in 12 quarters since.
280 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2019.

Based on Elkfork Partners's 13F filing for Q3 2019, filed 14 Nov 2019.